Global Market Access

Inferences:Government initiatives, particularly those supported by the NHS, are crucial in driving market growth. The aging population significantly contributes to the increasing demand...

Key TakeawaysZimmer Biomet has received FDA clearance for the Persona® SoluTion™ PPS® Femur, a cementless knee replacement component designed for patients with bone...

Key TakeawaysEPF emphasizes the importance of maintaining patient health as a top priority in EU policies. Collaboration on pharmaceutical legislation and health technology...

Key TakeawaysTafenoquine's approval accelerates malaria elimination efforts in multiple countries. The need for G6PD testing ensures safe administration, mitigating potential risks. Collaboration between...

Key TakeawaysThe creation of a new functional category by MHLW underscores the ClotTriever's distinct clinical benefits. The partnership with Medikit is pivotal for...

Welsh authorities have introduced a new dedicated platform aimed at providing extensive information on the use of sodium valproate among women and girls. This...

The United Kingdom and the Republic of Korea have embarked on a collaborative journey aimed at revolutionizing clinical trials. This partnership seeks to enhance...

Key TakeawaysLundbeck's acquisition enhances its position in the neuro-rare disease market, addressing unmet medical needs. Bexicaserin's advanced clinical development stage suggests a shorter...

Key TakeawaysNigeria loses over $1.1 billion annually due to malaria-related productivity losses and healthcare costs. Malaria accounts for 27% of global cases, with...

Key TakeawaysCubecover aims to provide affordable insurance to 10 million Nigerians by 2027. The insuretech company leverages strategic partnerships and technology to enhance...

ACE unveils a new suite of learning modules tailored for patients and the general public eager to delve into ACE's operational framework. These modules...

Biogen Japan has announced a groundbreaking research initiative focused on the APOE gene, a critical factor in Alzheimer's disease (AD) progression. Spearheaded by CEO...

Key TakeawaysIncreased prevalence of growth hormone deficiencies across age groups. Advancements in recombinant DNA technology enhancing treatment efficacy. Rise of biosimilars improving market...

Dr. Reddy's Laboratories, in collaboration with Senores Pharmaceuticals, has introduced Ivermectin Tablets USP, 3 mg, into the U.S. market. This generic version mirrors Merck's...

Edwards Lifesciences has unveiled promising one-year data for its latest SAPIEN 3 Ultra RESILIA valve at PCR London Valves 2024. The findings, also featured...